Therefore, in BC, PI3K/AKT pathway plays a fundamental oncogenic role, interacting with other canonical signaling pathways to drive tumor evolution and resistance to therapies [20,21] and modulating the expression of transcription factors, which play key roles in tumor cell migration and invasion [22,23]. This evidence concerns the gene AKT1 and breast cancer.